| 000 | 00765 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250517090105.0 | ||
| 264 | 0 | _c20190121 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1748-1716 | ||
| 024 | 7 |
_a10.1111/apha.12683 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPersson, P B | |
| 245 | 0 | 0 |
_aRenoprotection. _h[electronic resource] |
| 260 |
_bActa physiologica (Oxford, England) _c03 2017 |
||
| 300 |
_a540-541 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aProtective Agents _xpharmacology |
| 773 | 0 |
_tActa physiologica (Oxford, England) _gvol. 219 _gno. 3 _gp. 540-541 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apha.12683 _zAvailable from publisher's website |
| 999 |
_c25877587 _d25877587 |
||